pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 718 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
gepotidacin mesylate
Blujepa (gepotidacin mesylate)
Urinary Tract Infections
GlaxoSmithKline LLC
2 catalysts
Marketed
rezafungin acetate
Rezzayo (rezafungin acetate)
Fungal Infections
Napp Pharmaceuticals Ltd
2 catalysts
Marketed
(cilastatin sodium + imipenem + relebactam)
Recarbrio ((cilastatin sodium + imipenem + relebactam))
Complicated Intra-Abdominal Infections
$MRKMerck & Co., Inc.
3 catalysts
← prev
page 3 of 24
next →
131
Pain89
Neurology1
Marketed
RIFADIN
RIFADIN (RIFAMPIN)
Tuberculosis
Sanofi-Aventis US LLC
116 catalysts
Marketed
amikacin sulfate PR
Arikayce (amikacin sulfate)
Lung Infections
Bacterial 70S ribosome
$INSMINSMED Inc
6 catalysts
Marketed
VORICONAZOLE
VORICONAZOLE (VORICONAZOLE)
Aspergillosis
United Biomedical Inc
30 catalysts
Marketed
vonoprazan fumarate
Voquezna (vonoprazan fumarate)
Eosinophilic Esophagitis
Potassium-transporting ATPase
$PHATPhathom Pharmaceuticals, Inc.
3 catalysts
Marketed
ibrexafungerp citrate
Brexafemme (ibrexafungerp citrate)
Aspergillosis
1,3-beta-glucan synthase
$GSKGSK plc
4 catalysts
Marketed
amoxicillin + clarithromycin + vonoprazan
Voquezna Triple Pak (amoxicillin + clarithromycin + vonoprazan [INN])
Helicobacter pylori Infections
$PHATPhathom Pharmaceuticals, Inc.
6 catalysts
Marketed
amoxicillin + vonoprazan fumarate
Voquezna Dual Pak (amoxicillin + vonoprazan fumarate)
Helicobacter pylori Infections
$PHATPhathom Pharmaceuticals, Inc.
6 catalysts
Marketed
(doravirine + lamivudine + tenofovir disoproxil fumarate)
Delstrigo ((doravirine + lamivudine + tenofovir disoproxil fumarate))
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Merck Sharp & Dohme Corp (Inactive)
7 catalysts
Marketed
doravirine
Pifeltro (doravirine)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Merck Sharp & Dohme Corp (Inactive)
6 catalysts
Marketed
remdesivir
Veklury (remdesivir)
Coronavirus Disease 2019 (COVID-19)
$GILDGILEAD SCIENCES, INC.
23 catalysts
Marketed
ETRAVIRINE
ETRAVIRINE (ETRAVIRINE)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Janssen Therapeutics
1 catalysts
Marketed
CIPROFLOXACIN HYDROCHLORIDE
CIPROFLOXACIN HYDROCHLORIDE (CIPROFLOXACIN HYDROCHLORIDE)
Acute Uncomplicated Cystitis In Women
NuCare Pharmaceuticals Inc
23 catalysts
Phase 3
(Coronavirus disease 2019 (COVID-19) + influenza (trivalent)) vaccine
Coronavirus Disease 2019 (COVID-19)
$NVAXNOVAVAX INC
0 catalysts
Marketed
(abacavir sulfate + lamivudine)
Abacavir Sulfate + Lamivudine Prasco ((abacavir sulfate + lamivudine))
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Prasco LLC
0 catalysts
Marketed
(acyclovir + hydrocortisone)
Xerese ((acyclovir + hydrocortisone [INN]))
Herpes Labialis (Oral Herpes)
Bausch Health US LLC
0 catalysts
Marketed
(amoxicillin + omeprazole magnesium+ rifabutin) DR
Talicia ((amoxicillin + omeprazole magnesium + rifabutin))
Helicobacter pylori Infections
$RDHLRedHill Biopharma Ltd.
0 catalysts
Marketed
(ampicillin sodium + sulbactam sodium)
Ampicillin + Sulbactam ((ampicillin sodium + sulbactam sodium))
Complicated Intra-Abdominal Infections
Mylan Pharmaceuticals Inc
0 catalysts
Marketed
(artemether + lumefantrine)
Coartem ((artemether + lumefantrine))
Malaria
$NVSNOVARTIS AG
0 catalysts
Marketed
(atazanavir sulfate + cobicistat)
Evotaz ((atazanavir sulfate + cobicistat))
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Bristol-Myers Squibb Co
0 catalysts
Marketed
(atoltivimab + maftivimab + odesivimab)
Inmazeb ((atoltivimab + maftivimab + odesivimab-ebgn))
Ebolavirus Infections (Ebola Hemorrhagic Fever)
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Marketed
(atovaquone + proguanil hydrochloride)
Atovaquone + Proguanil Hydrochloride Prasco ((atovaquone + proguanil hydrochloride))
Malaria
Prasco LLC
0 catalysts
Marketed
(avibactam sodium + aztreonam)
Emblaveo ((avibactam sodium + aztreonam))
Complicated Intra-Abdominal Infections
$ABBVAbbVie Inc.
0 catalysts
Marketed
(avibactam sodium + ceftazidime)
Avycaz ((avibactam sodium + ceftazidime))
Pyelonephritis
$ABBVAbbVie Inc.
0 catalysts
Phase 3
(bemnifosbuvir + ruzasvir)
Hepatitis C
$AVIRAtea Pharmaceuticals, Inc.
0 catalysts
Preclinical
(benznidazole + pyronaridine)
(benznidazole + pyronaridine (INN))
Chagas Disease (American Trypanosomiasis)
Collaborations Pharmaceuticals Inc
0 catalysts
Marketed
(betamethasone acetate + betamethasone sodium phosphate)
Celestone Soluspan ((betamethasone acetate + betamethasone sodium phosphate))
Cerebral Edema
$OGNOrganon & Co.
0 catalysts
Marketed
(betamethasone dipropionate + clotrimazole)
Clotrimazole + Betamethasone Dipropionate ((betamethasone dipropionate + clotrimazole))
Tinea Corporis
Fougera Pharmaceuticals Inc
0 catalysts